Sterile Fill Finish
Spokane Facility Expansion
Investing in People and Technology to Double Our Capacity Jubilant HollisterStier broke ground for our $285Mn Spokane facility expansion project on November 17, 2021. This...
Jubilant HollisterStier Celebrates the Opening of Their Third Manufacturing Line with a Ribbon Cutting Ceremony
02.09.2024, Spokane, WA – Jubilant HollisterStier held a ribbon cutting ceremony on February 8, celebrating the opening of their third sterile fill finish manufacturing line...
Exploring CMO Strategies with Chris Preti (DCAT Week)
In June of 2023, Chris Preti, CEO of Jubilant HollisterStier CMO, met with Grant Playter, associate editor of Pharmtech.com, at the 2023 DCAT Week conference. Topics of...
Jubilant HollisterStier Appoints Chris Preti President
On March 16 2023, Contract Pharma sat down and interviewed Chris Preti, when he was appointed as president of Jubilant HollisterStier. Chris Preti has more than 25 years of...
Jubilant HollisterStier Receives Five CMO Leadership Awards 2022
03.16.2022, Spokane, WA & Montreal, CA: Jubilant HollisterStier LLC, a leading pharmaceutical contract manufacturer and a subsidiary of Jubilant Pharma Limited, today...
Jubilant HollisterStier to Pump $76M into Montreal Facility
On July 14 2021, Fierce Pharma reported on the $76Mn expansion of the Jubilant HollisterStier CDMO facility in Montreal, Canada. This investment doubled the facility’s drug...
Jubilant HollisterStier, Lilly Enter Bamlanivimab Mfg. Pact
In March 2021, during the height of the COVID-19 pandemic, Contract Pharma wrote an article detailing Jubilant HollisterStier’s contract with Eli Lilly to manufacture a...